BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,063 filers reported holding BAXTER INTL INC in Q3 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $229,648 | -17.2% | 6,085 | 0.0% | 0.01% | -10.0% |
| Q2 2023 | $277,233 | +12.3% | 6,085 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $246,808 | -10.1% | 6,085 | 0.0% | 0.01% | -9.1% |
| Q4 2022 | $274,677 | -20.2% | 6,085 | -4.7% | 0.01% | -26.7% |
| Q3 2022 | $344,000 | -16.1% | 6,387 | 0.0% | 0.02% | -16.7% |
| Q2 2022 | $410,000 | -17.2% | 6,387 | 0.0% | 0.02% | 0.0% |
| Q1 2022 | $495,000 | -14.4% | 6,387 | -5.1% | 0.02% | -5.3% |
| Q4 2021 | $578,000 | +6.6% | 6,732 | -0.2% | 0.02% | -5.0% |
| Q3 2021 | $542,000 | -3.9% | 6,748 | -3.7% | 0.02% | 0.0% |
| Q2 2021 | $564,000 | -4.6% | 7,006 | 0.0% | 0.02% | -13.0% |
| Q1 2021 | $591,000 | -0.8% | 7,006 | -5.7% | 0.02% | -14.8% |
| Q4 2020 | $596,000 | -4.3% | 7,432 | -4.0% | 0.03% | -3.6% |
| Q3 2020 | $623,000 | -10.5% | 7,743 | -4.2% | 0.03% | -15.2% |
| Q2 2020 | $696,000 | +3.0% | 8,079 | -3.0% | 0.03% | -13.2% |
| Q1 2020 | $676,000 | -6.1% | 8,330 | -3.2% | 0.04% | +18.8% |
| Q4 2019 | $720,000 | -4.8% | 8,605 | -0.5% | 0.03% | -8.6% |
| Q3 2019 | $756,000 | +11.2% | 8,644 | +4.0% | 0.04% | +12.9% |
| Q2 2019 | $680,000 | -2.6% | 8,311 | -3.2% | 0.03% | -3.1% |
| Q1 2019 | $698,000 | +17.9% | 8,582 | -4.7% | 0.03% | 0.0% |
| Q4 2018 | $592,000 | -14.7% | 9,009 | 0.0% | 0.03% | 0.0% |
| Q3 2018 | $694,000 | +1.6% | 9,009 | -2.8% | 0.03% | -3.0% |
| Q2 2018 | $683,000 | +1.0% | 9,266 | -10.9% | 0.03% | +3.1% |
| Q1 2018 | $676,000 | -17.7% | 10,405 | -4.8% | 0.03% | -13.5% |
| Q4 2017 | $821,000 | +17.8% | 10,928 | -2.9% | 0.04% | +12.1% |
| Q3 2017 | $697,000 | +2.3% | 11,258 | 0.0% | 0.03% | 0.0% |
| Q2 2017 | $681,000 | +16.6% | 11,258 | 0.0% | 0.03% | +13.8% |
| Q1 2017 | $584,000 | +11.5% | 11,258 | -4.8% | 0.03% | +11.5% |
| Q4 2016 | $524,000 | -6.8% | 11,820 | 0.0% | 0.03% | -16.1% |
| Q3 2016 | $562,000 | +12.6% | 11,820 | +7.1% | 0.03% | -3.1% |
| Q2 2016 | $499,000 | +18.0% | 11,036 | +7.1% | 0.03% | +14.3% |
| Q1 2016 | $423,000 | +7.6% | 10,308 | 0.0% | 0.03% | +3.7% |
| Q4 2015 | $393,000 | +16.3% | 10,308 | 0.0% | 0.03% | +12.5% |
| Q3 2015 | $338,000 | -53.1% | 10,308 | 0.0% | 0.02% | -48.9% |
| Q2 2015 | $721,000 | +3.9% | 10,308 | +1.8% | 0.05% | +4.4% |
| Q1 2015 | $694,000 | -6.5% | 10,128 | 0.0% | 0.04% | -11.8% |
| Q4 2014 | $742,000 | +3.3% | 10,128 | +1.2% | 0.05% | 0.0% |
| Q3 2014 | $718,000 | -7.5% | 10,010 | -6.7% | 0.05% | -8.9% |
| Q2 2014 | $776,000 | -1.8% | 10,734 | 0.0% | 0.06% | -9.7% |
| Q1 2014 | $790,000 | -0.3% | 10,734 | -5.8% | 0.06% | -1.6% |
| Q4 2013 | $792,000 | +4.6% | 11,392 | -1.2% | 0.06% | -11.3% |
| Q3 2013 | $757,000 | – | 11,525 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |